{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:10:11Z","timestamp":1788995411866,"version":"build-2803163510"},"reference-count":17,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,9,14]],"date-time":"2015-09-14T00:00:00Z","timestamp":1442188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurourology and Urodynamics"],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>Refractory overactive bladder (OAB) treatments, including sacral neuromodulation (SNM), onabotulinumtoxin A (OnabotA), and percutaneous tibial nerve stimulation (PTNS), differ considerably. Best\u2010Worst Scaling (BWS) was used to assess patient preferences for these treatments.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A cross\u2010sectional Web survey, based on findings from qualitative interviews with 23 OAB patients and 7 clinical experts, was conducted with idiopathic OAB patients in the US and UK. The BWS exercise involved prioritizing subsets of 13 attributes across 13 choice tasks, where patients identified the attribute they considered as best and as worst in each task. Attribute BWS scores, ranging from \u22121.0 (worst) to 1.0 (best) were calculated based on the rates that each attribute was chosen. Attitudes toward the attributes also were assessed via like\/dislike Likert scales, and questions regarding the percentage likelihood (0\u2013100%) of trying each treatment, based on standardized treatment descriptions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The sample included 245 patients (118 US, 127 UK); 79% female, mean age 50\u2009\u00b1\u20097.8 years. All 13 attribute BWS scores were significantly positive or negative. \u201cLasting improvement\u201d (0.82), \u201cminimal side effects\u201d (0.67), and \u201csends signals between bladder and brain\u201d (0.35)' were rated most favorably, and \u201ccomplications with implant\u201d (\u22120.65), and \u201cbe willing to self\u2010catheterize\u201d (\u22120.53) were rated worst. All but one of the attribute BWS scores were significantly correlated with the respective like\/dislike scores and the percentage likelihood estimates for trying one of the three treatments.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>BWS was successful in assessing the magnitude of patient preferences for key attributes associated with substantially different refractory OAB therapies. <jats:italic>Neurourol. Urodynam. 35:1028\u20131033, 2016<\/jats:italic>. \u00a9 2015 Wiley Periodicals, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/nau.22876","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T00:01:21Z","timestamp":1442275281000},"page":"1028-1033","source":"Crossref","is-referenced-by-count":11,"title":["Use of best\u2010worst scaling to assess patient perceptions of treatments for refractory overactive bladder"],"prefix":"10.1002","volume":"35","author":[{"given":"Kathleen","family":"Beusterien","sequence":"first","affiliation":[{"name":"ORS Health Washington DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Kennelly","sequence":"additional","affiliation":[{"name":"Women's Center for Pelvic Health, Carolinas Heathcare System Charlotte North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.P.","family":"Bridges","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management Johns Hopkins Bloomberg School of Public Health Baltimore Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlan","family":"Amos","sequence":"additional","affiliation":[{"name":"ORS Health Washington DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Jo","family":"Williams","sequence":"additional","affiliation":[{"name":"Medtronic Minneapolis Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip","family":"Vasavada","sequence":"additional","affiliation":[{"name":"Center for Female Pelvic Medicine and Reconstructive Surgery Glickman Urological Institute Cleveland Clinic Cleveland Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,9,14]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2012.09.028"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2015.01.087"},{"key":"e_1_2_6_4_1","unstructured":"IUGA 2013: International Urogyneocological Association. Sacral Neuromodulaton: A guide for women. 2013. Available from:http:\/\/c.ymcdn.com\/sites\/www.iuga.org\/resource\/resmgr\/brochures\/eng_sacralneuro.pdf"},{"key":"e_1_2_6_5_1","first-page":"198","article-title":"Botulinum toxin for the treatment of idiopathic and neurogenic overactive bladder: State of the art","volume":"8","author":"Nitti VW","year":"2006","journal-title":"Rev Urol"},{"key":"e_1_2_6_6_1","unstructured":"WalshJ Percutaneous tibial nerve stimulation for the treatment of overactive bladder. California Technology Assessment Forum. June2012Available from 2012;http:\/\/ctaf.org\/sites\/default\/files\/assessments\/PTNS%20June%202012_0.pdf"},{"key":"e_1_2_6_7_1","doi-asserted-by":"crossref","unstructured":"Ryan. Using conjoint analysis to elicit preferences for health care. BMJ.2000320:1530.","DOI":"10.1136\/bmj.320.7248.1530"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.08.2223"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1586\/erp.10.29"},{"key":"e_1_2_6_10_1","unstructured":"UmbergerW StringerR MuellerSC.Selected Paper prepared for presentation at the Agricultural & Applied Economics. Using Best\u2010Worst Scaling to Determine Market Channel Choice by Small Farmers in Indonesia. Association 2010 AAEA CAES & WAEA Joint Annual Meeting Denver Colorado July 25\u201027 2010. Available from: file:\/\/\/C:\/Users\/HP\/Downloads\/09e41509c80e7d6875000000.pdf"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2014.04.011"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-014-0104-x"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1037\/0003-066X.58.1.78"},{"key":"e_1_2_6_14_1","first-page":"180","article-title":"Patient defined goals of care in treatment of medication refractory overactive bladder","volume":"33","author":"Levy M","year":"2014","journal-title":"Neurourol Urodyn"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.09.090"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1159\/000316080"},{"key":"e_1_2_6_17_1","unstructured":"MDIC 2015: Medical Device Innovation Consortium Patient Centered Benefit\u2010Risk Project Report 2015:http:\/\/mdic.org\/wp-content\/uploads\/2015\/05\/MDIC_PCBR_Framework_Proof5_Web.pdf"},{"key":"e_1_2_6_18_1","unstructured":"CDRH: Draft Guidance on Patient Preference Information\u2010Submission Review in PMAs HDE Applications and De Novo Requests and Inclusion in Device Labeling Issued May 182015;http:\/\/www.fda.gov\/ucm\/groups\/fdagov\u2010public\/@fdagov\u2010meddev\u2010gen\/documents\/document\/ucm446680.pdf"}],"container-title":["Neurourology and Urodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fnau.22876","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/nau.22876","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T20:26:12Z","timestamp":1696364772000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/nau.22876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,14]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.1002\/nau.22876"],"URL":"https:\/\/doi.org\/10.1002\/nau.22876","archive":["Portico"],"relation":{},"ISSN":["0733-2467","1520-6777"],"issn-type":[{"value":"0733-2467","type":"print"},{"value":"1520-6777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,14]]}}}